The growing field of immunotherapy relies heavily on recombinant growth factor technology, and a thorough understanding of individual profiles is essential for fine-tuning experimental design and therapeutic efficacy. Specifically, examining the attributes of recombinant IL-1A, IL-1B, IL-2, and IL-3 reveals significant differences in their structur